Page 8 - Trial Network News Today

Collaboration will strengthen and amplify identification of patients with Neurotrophic Tyrosine Receptor Kinase (NTRK) fusion-positive solid tumors potentially...

/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect people from infectious...

/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect people from infectious...

University of Utah Health researchers are leading a five-year, $22-million nationwide clinical trial for NMDA receptor encephalitis––a type of autoimmune encephalitis that prompts the immune system to mistakenly attack the brain, causing confusion, memory loss, seizures, and symptoms similar to bipolar disorder and other psychiatric conditions.

/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect people from infectious...

Washington: After undergoing a stem cell transplant, a leukaemia patient in the United States has become the first woman and third person to be cured of HIV, the virus that causes AIDS, according to researchers.

NIH confirms the third HIV remission case. The unnamed patient no longer experience symptoms after getting her stem cell transplant.

First women gets cured of HIV after stem cell transplant - As per researchers, no HIV was detected in the participant for 14 months except for a transient detection of trace levels of HIV DNA

The woman appears to be HIV-free following a new transplant method using umbilical cord blood.

GuruFocus Article or News written by PRNewswire and the topic is about: